RU2001105164A - MEANS FOR TREATMENT OF DERMATOLOGICAL DISEASES - Google Patents

MEANS FOR TREATMENT OF DERMATOLOGICAL DISEASES

Info

Publication number
RU2001105164A
RU2001105164A RU2001105164/14A RU2001105164A RU2001105164A RU 2001105164 A RU2001105164 A RU 2001105164A RU 2001105164/14 A RU2001105164/14 A RU 2001105164/14A RU 2001105164 A RU2001105164 A RU 2001105164A RU 2001105164 A RU2001105164 A RU 2001105164A
Authority
RU
Russia
Prior art keywords
dermatological diseases
treatment
trilon
emulsifier
emulsifying
Prior art date
Application number
RU2001105164/14A
Other languages
Russian (ru)
Other versions
RU2197247C2 (en
Inventor
Николай Александрович Ляпунов
Алевтина Григорьевна Фадейкина
Янина Францевна Кутасевич
Ирина Алексеевна Маштакова
Оксана Алексеевна Ляпунова
Леонид Александрович Чайка
Виктория Витальевна Либина
Наталья Сергеевна Никитина
Людмила Николаевна Бобкова
Original Assignee
Закрытое акционерное общество "ФАРМАЦЕВТИЧЕСКАЯ ФИРМА "ДАРНИЦА"
Государственный научный центр лекарственных средств
Filing date
Publication date
Application filed by Закрытое акционерное общество "ФАРМАЦЕВТИЧЕСКАЯ ФИРМА "ДАРНИЦА", Государственный научный центр лекарственных средств filed Critical Закрытое акционерное общество "ФАРМАЦЕВТИЧЕСКАЯ ФИРМА "ДАРНИЦА"
Priority to RU2001105164A priority Critical patent/RU2197247C2/en
Priority claimed from RU2001105164A external-priority patent/RU2197247C2/en
Application granted granted Critical
Publication of RU2197247C2 publication Critical patent/RU2197247C2/en
Publication of RU2001105164A publication Critical patent/RU2001105164A/en

Links

Claims (1)

Средство для лечения дерматологических заболеваний, содержащее флуоцинолона ацетонид, пропиленгликоль и вазелин, отличающееся тем, что дополнительно содержит нипагин, парафин твердый, масло вазелиновое, эмульгатор № 1 или спирт цетостеариловый эмульгирующий, трилон Б и воду очищенную при следующем соотношении компонентов, мас.%:An agent for treating dermatological diseases containing fluocinolone acetonide, propylene glycol and petroleum jelly, characterized in that it further comprises nipagin, solid paraffin, liquid paraffin, emulsifier No. 1 or emulsifying cetostearyl alcohol, Trilon B and purified water in the following ratio, wt.%: Флуоцинолона ацетонид 0,025-0,2Fluocinolone Acetonide 0.025-0.2 Нипагин 0,05-0,25Nipagin 0.05-0.25 Пропиленгликоль 2,0-10,0Propylene glycol 2.0-10.0 Парафин твердый 3,0-12,0Hard paraffin 3.0-12.0 Вазелин 1,0-4,0Vaseline 1.0-4.0 Масло вазелиновое 6,0-24,0Vaseline oil 6.0-24.0 Эмульгатор № 1 или спирт цетостеариловый эмульгирующий 4,0-10,0Emulsifier No. 1 or cetostearyl emulsifying alcohol 4.0-10.0 Трилон Б 0,05-0,5Trilon B 0.05-0.5 Вода очищенная ОстальноеPurified Water
RU2001105164A 2001-02-26 2001-02-26 Agent for treatment of dermatological diseases RU2197247C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2001105164A RU2197247C2 (en) 2001-02-26 2001-02-26 Agent for treatment of dermatological diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2001105164A RU2197247C2 (en) 2001-02-26 2001-02-26 Agent for treatment of dermatological diseases

Publications (2)

Publication Number Publication Date
RU2197247C2 RU2197247C2 (en) 2003-01-27
RU2001105164A true RU2001105164A (en) 2003-08-27

Family

ID=20246458

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001105164A RU2197247C2 (en) 2001-02-26 2001-02-26 Agent for treatment of dermatological diseases

Country Status (1)

Country Link
RU (1) RU2197247C2 (en)

Similar Documents

Publication Publication Date Title
RU2384580C2 (en) Phosphatidylinositol-3-kinase inhibitors
EP2329842A3 (en) Interleukin-1 inhibitors in the treatment of diseases
BR0213358A (en) Flibanserin use
ATE482723T1 (en) SEMI-SOLID MUCOADHESIVE FORMULATIONS
BRPI0415121A (en) particulate material, solid dosage form, method of manufacturing it, and use of a particulate material or solid dosage form
WO2003015699A3 (en) Topical compositions and methods for treating pain
KR970701049A (en) COMPOSITIONS CONTAINING PROSTAGLANDIN E1 AND OR TROXERUTINE COMPLEXED WITH PHOSPHATIDYLCHOLINE FOR TOPICAL TREATMENT OF ERECTILE IMPOTENCE
PT1267832E (en) AUTO-EMULSIFYING SYSTEM OF LIBERATION OF PHARMACO
ES2192832T3 (en) USE OF MACROLID COMPOUNDS TO TREAT GLAUCOMA.
DE60115402D1 (en) NEW SELF-SUCCESSING DRUG DISPOSAL SYSTEM
ATE277608T1 (en) 2-ARACHIDONYL GLYCEROL, AN INHIBITOR OF TUMOR NECROSIS FACTOR -ALFA AND BRAIN NEUROPROTECTOR IN CLOSED HEAD INJURIES
RU2001105164A (en) MEANS FOR TREATMENT OF DERMATOLOGICAL DISEASES
HUP9802431A2 (en) Pharmaceutical compns. contg. pentosan polysulfate for the treatment of chronic progressive vascular diseases
KR930019224A (en) Abortion Hazard Remedy
FR2909556B1 (en) PHOTOPROTECTIVE CREAM BASED ON FATTY ACID
ATE405276T1 (en) PHARMACEUTICAL GEL COMPOSITION
RU2002106828A (en) EMULSION "ENDOMETRICITIS" FOR PREVENTION AND TREATMENT OF POST-PERMANENT DISEASES IN COWS
DE60122764D1 (en) USE OF CORTISOL SEQUESTRIES FOR THE TREATMENT OF HYPERCORTISOLAEMY-RELATED DISEASES
RU2002110952A (en) Cream "Bramisil" antifungal action
KR970005294A (en) Eye wash water containing bamboo power and bamboo salt as active ingredients
UA49159A (en) Composition intended for treating dermatological diseases
DK0998929T3 (en) Topical pharmaceutical compositions for wound healing comprising borneol and bismuth subgallate
WO2005055975A3 (en) Uv-stable semi-solid transdermal systems comprising a photosensitive active ingredient and a uv absorber
RU2000118939A (en) PREPARATION "DENAGIF" FOR THE TREATMENT AND PREVENTION OF POST-NORTH ENDOMETRITIS IN COWS
RU2003123668A (en) DIAGNOSTIC METHOD FOR VARICOSE EXTENDED VALVES OF THE SMALL PELVIS